Cargando…
An Overview of MicroRNAs as Biomarkers of ALS
Amyotrophic lateral sclerosis (ALS; MND, motor neuron disease) is a debilitating neurodegenerative disease affecting 4.5 per 100,000 people per year around the world. There is currently no cure for this disease, and its causes are relatively unknown. Diagnosis is based on a battery of clinical tests...
Autores principales: | Joilin, Greig, Leigh, P. Nigel, Newbury, Sarah F., Hafezparast, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416171/ https://www.ncbi.nlm.nih.gov/pubmed/30899244 http://dx.doi.org/10.3389/fneur.2019.00186 |
Ejemplares similares
-
Corrigendum: An Overview of MicroRNAs as Biomarkers of ALS
por: Joilin, Greig, et al.
Publicado: (2019) -
Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis
por: Christoforidou, Eleni, et al.
Publicado: (2020) -
Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients
por: Joilin, Greig, et al.
Publicado: (2022) -
Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis
por: Joilin, Greig, et al.
Publicado: (2020) -
Extracellular Vesicle Proteins and MicroRNAs as Biomarkers for Traumatic Brain Injury
por: Guedes, Vivian A., et al.
Publicado: (2020)